Apixaban at Apex? Aligning Drug Pricing With Value in Cancer-Associated Thrombosis

Ann Intern Med. 2023 Jan;176(1):125-126. doi: 10.7326/M22-3404. Epub 2022 Dec 27.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants
  • Drug Costs
  • Factor Xa Inhibitors
  • Humans
  • Neoplasms* / complications
  • Neoplasms* / drug therapy
  • Pyridones / therapeutic use
  • Thrombosis* / drug therapy
  • Thrombosis* / etiology
  • Thrombosis* / prevention & control

Substances

  • apixaban
  • Pyridones
  • Anticoagulants
  • Factor Xa Inhibitors